Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia. Issue 12 (19th October 2022)
- Record Type:
- Journal Article
- Title:
- Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia. Issue 12 (19th October 2022)
- Main Title:
- Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia
- Authors:
- Seko, Yuya
Kawanaka, Miwa
Fujii, Hideki
Iwaki, Michihiro
Hayashi, Hideki
Toyoda, Hidenori
Oeda, Satoshi
Hyogo, Hideyuki
Morishita, Asahiro
Munekage, Kensuke
Kawata, Kazuhito
Yamamura, Sakura
Sawada, Koji
Maeshiro, Tatsuji
Tobita, Hiroshi
Yoshida, Yuichi
Naito, Masafumi
Araki, Asuka
Arakaki, Shingo
Kawaguchi, Takumi
Noritake, Hidenao
Ono, Masafumi
Masaki, Tsutomu
Yasuda, Satoshi
Tomita, Eiichi
Yoneda, Masato
Tokushige, Akihiro
Kamada, Yoshihiro
Takahashi, Hirokazu
Ueda, Shinichiro
Aishima, Shinichi
Sumida, Yoshio
Okanoue, Takeshi
Itoh, Yoshito
Nakajima, Atsushi
… (more) - Abstract:
- Abstract: Background and Aim: Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD). Methods: We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy‐proven NAFLD. The median follow‐up was 4.6 years. Results: The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow‐up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. Conclusion: Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age‐dependent screening andAbstract: Background and Aim: Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD). Methods: We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy‐proven NAFLD. The median follow‐up was 4.6 years. Results: The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow‐up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. Conclusion: Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age‐dependent screening and management strategies is necessary for patients with NAFLD. … (more)
- Is Part Of:
- Journal of gastroenterology and hepatology. Volume 37:Issue 12(2022)
- Journal:
- Journal of gastroenterology and hepatology
- Issue:
- Volume 37:Issue 12(2022)
- Issue Display:
- Volume 37, Issue 12 (2022)
- Year:
- 2022
- Volume:
- 37
- Issue:
- 12
- Issue Sort Value:
- 2022-0037-0012-0000
- Page Start:
- 2313
- Page End:
- 2320
- Publication Date:
- 2022-10-19
- Subjects:
- age -- BMI -- CLIONE in Asia -- fibrosis -- hepatocellular carcinoma -- liver‐related events -- non‐alcoholic fatty liver disease -- non‐alcoholic steatohepatitis -- obesity -- type 2 diabetes mellitus
Gastroenterology -- Periodicals
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Liver Diseases -- Periodicals
616.33 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1746 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/loi/jgh ↗ - DOI:
- 10.1111/jgh.16019 ↗
- Languages:
- English
- ISSNs:
- 0815-9319
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4987.615000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24693.xml